Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2024-04-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
2024年度财务预算报告
Regulatory Filings Classification · 85% confidence The document is titled as a '2024年度财务预算报告' which translates to '2024 Annual Financial Budget Report'. It contains budget planning, assumptions, and forecasted financial targets for the year 2024. It explicitly states that it is an internal management control indicator and not a profit forecast. The document length is short (822 characters), and it does not contain actual financial statements or detailed financial results. It also references other announcements for financing plans, indicating this document is a budget plan rather than a formal financial report or announcement. Given these characteristics, it does not fit the categories of Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or Capital/Financing Update (CAP) since it does not report actual results or financing events but rather a budget plan. It is also not a report publication announcement or regulatory filing since it contains substantive content. The best fitting category is Regulatory Filings (RNS) as a fallback for miscellaneous filings that do not neatly fit into other categories, especially for internal budget reports and planning documents.
2024-04-26 Chinese
2023年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2023年度董事会工作报告' which translates to '2023 Annual Board of Directors Work Report'. It details the board's activities throughout the year 2023, including meetings held, resolutions passed, board re-elections, committee work, independent director evaluations, information disclosure, and investor relations. It contains detailed operational and governance information about the board's work rather than financial statements or audit results. The document is comprehensive and lengthy (over 13,000 characters), indicating it is a full report rather than a brief announcement. The content focuses on board and management activities, including changes in board composition and governance practices, which aligns with the category for Board/Management Information (MANG). It is not an Annual Report (10-K) as it lacks full financial statements and comprehensive company performance data, nor is it an Audit Report or other categories. Therefore, the best fit is Board/Management Information (MANG).
2024-04-26 Chinese
审计委员会对会计师事务所履行监督职责情况的报告
Audit Report / Information Classification · 95% confidence The document is a report from the Audit Committee regarding the supervision of the accounting firm Tianzhi International for the 2023 annual audit. It discusses the audit firm's qualifications, the audit process, communication with auditors, and the committee's evaluation of the audit work related to the 2023 annual report. The document does not contain the full annual report or financial statements but is a standalone report on audit supervision and audit quality. It fits the definition of an Audit Report / Information (AR) as it is a standalone audit-related report, not the full annual report itself. The document length is 1645 characters, which is short and focused on audit supervision, not a report publication announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2023
2024-04-26 Chinese
重庆化医控股集团财务有限公司风险评估报告
Audit Report / Information Classification · 95% confidence The document is titled as a "风险评估报告" (Risk Assessment Report) issued by a registered accounting firm (天职国际会计师事务所) for 重庆化医控股集团财务有限公司. It contains detailed information about the company's internal control systems, risk management policies, regulatory compliance, financial data as of December 31, 2023, and audit opinions. The document includes extensive descriptions of governance structures, risk identification, control activities, and compliance with regulatory requirements. It is not a full annual report but a standalone audit-related report focusing on risk assessment and internal controls. The presence of an audit opinion and detailed risk evaluation aligns with the definition of an Audit Report / Information (AR). The document length (12,006 characters) and content confirm it is the report itself, not merely an announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2023
2024-04-26 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the supervisory board of the company regarding multiple reports and proposals related to the 2023 fiscal year and 2024 plans. It references the approval of various reports such as the 2023 annual report, financial statements, internal control reports, ESG report, and the 2024 first quarter report. However, the document itself does not contain the full reports or detailed financial data but rather announces the supervisory board's approval and the intention to submit these matters to the shareholders' meeting. It also repeatedly states that the detailed contents are disclosed separately on the same day. The document length is relatively short (2547 characters), and it serves as a formal meeting resolution announcement rather than the actual reports. Therefore, according to the MENU VS MEAL RULE and the nature of the content, this document is best classified as a Regulatory Filing (RNS) because it is a formal announcement of supervisory board resolutions and approvals without the full report content.
2024-04-26 Chinese
关于续聘会计师事务所的公告
Regulatory Filings Classification · 90% confidence The document is an announcement regarding the reappointment of an accounting firm (auditor) for the company. It details the auditor's qualifications, independence, audit fees, and the approval process by the audit committee and board of directors. It does not contain any actual audit report, financial statements, or detailed audit results. The document is relatively short (2713 characters) and serves as a formal announcement of the auditor reappointment rather than the audit report itself. Therefore, it fits best under the category of Audit Report / Information (AR) since it relates to audit matters but is not a full annual report or audit report document. However, given the document is an announcement about the auditor reappointment and not the audit report itself, it is more appropriate to classify it as Regulatory Filings (RNS) as a general regulatory announcement about audit firm appointment, not the audit report or annual report itself.
2024-04-26 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.